Pharmas Urge India Health Ministry To Settle With Clinical-Trial Advocates
This article was originally published in PharmAsia News
Executive Summary
Court-ordered regulatory changes in India have led to a large slowdown in approvals for clinical trials around the country, down from 170 during the first five months of 2013 to just 25 so far this year.